# Petmed Express Inc: Form 10-Q for the period ended Dec 31, 2018

- Company: [Petmed Express Inc](/companies/pets.md) (CIK 1040130)
- Form: 10-Q
- Filed: 2019-01-29
- Accepted by EDGAR: Jan 29, 2019, 12:01 ET
- Period: 2018-12-31
- Accession: 0001437749-19-001477
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1040130/000143774919001477/pets20181231_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1040130/000143774919001477/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 9 months, 2018-04-01 to 2018-12-31 | $218.9m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2018-10-01 to 2018-12-31 | $40.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-04-01 to 2018-12-31 | $144.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-10-01 to 2018-12-31 | $19.4m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-04-01 to 2018-12-31 | $74.6m | us-gaap:GrossProfit |
| Operating income | 3 months, 2018-10-01 to 2018-12-31 | $9.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-04-01 to 2018-12-31 | $38.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-10-01 to 2018-12-31 | $2.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-04-01 to 2018-12-31 | $9.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-10-01 to 2018-12-31 | $7.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-04-01 to 2018-12-31 | $31.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-10-01 to 2018-12-31 | $0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-04-01 to 2018-12-31 | $1.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-10-01 to 2018-12-31 | $0.38 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-04-01 to 2018-12-31 | $1.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-10-01 to 2018-12-31 | 20,493,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-04-01 to 2018-12-31 | 20,487,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-04-01 to 2018-12-31 | $32.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-04-01 to 2018-12-31 | $507.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-04-01 to 2018-12-31 | $16.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2018-12-31 | $93.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-12-31 | $128.5m | us-gaap:AssetsCurrent |
| Total assets | at 2018-12-31 | $156.9m | us-gaap:Assets |
| Current liabilities | at 2018-12-31 | $23.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-12-31 | $24.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-12-31 | $132.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 22,220 characters.

### Executive Summary

PetMed Express was incorporated in the state of Florida in January 1996. The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol “PETS.” The Company began selling pet medications and other pet health products in September 1996. In March 2010, the Company started offering for sale additional pet supplies on its website, and these items are drop shipped to customers by third party vendors. Presently, the Company’s product line includes approximately 3,000 of the most popular pet medications, health products, and supplies for dogs and cats.

The Company markets its products through national advertising campaigns which aim to increase the recognition of the “1-800-PetMeds” brand name, and “PetMeds” family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. Approximately 84% of all sales were generated via the Internet for both the quarters ended December 31, 2018 and 2017. The Company’s sales consist of products sold mainly to retail consumers. The three-month average purchase was approximately $84 and $86 per order for the quarters ended December 31, 2018 and 2017, respectively, and for the nine months ended December 31, 2018 and 2017, the average purchase was approximately $87 and $86 per order, respectively.

### Critical Accounting Policies

Our discussion and analysis of our financial condition and the results of our operations are based upon our Condensed Consolidated Financial Statements and the data used to prepare them. The Company’s Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America. On an ongoing basis we re-evaluate our judgments and estimates including those related to product returns, bad debts, inventories, and income taxes. We base our estimates and judgments on our historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions. Our estimates are guided by observing the following critical accounting policies.

Revenue recognition

The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company’s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product; customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns; however this is not considered a key judgment. There are no amounts excluded from variable consideration. Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.

Outbound shipping and handling fees are an accounting policy election, and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales. The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales.

The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers’ inability to make required payments, arising from either credit card charge-backs or insufficient funds checks. The Company determines its estimates of the uncollectibility of accounts receivable by analyzing historical bad debts and current economic trends. The allowance for doubtful accounts was approximately $19,000 at December 31, 2018 compared to $35,000 at March 31, 2018.

Valuation of inventory

Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or market value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence. The inventory reserve was approximately $81,000 at December 31, 2018 compared to $58,000 at March 31, 2018.

Advertising

The Company's advertising expense consists primarily of Internet marketing and direct mail/print advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed when the related catalogs, brochures, and postcards are produced, distributed, or superseded.

Accounting for income taxes

The Company accounts for income taxes under the provisions of ASC Topic 740 (“*Accounting for Income Taxes”*), which generally requires recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the Consolidated Financial Statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities, and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.

### Results of Operations

The following should be read in conjunction with the Company’s Condensed Consolidated Financial Statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain operating data appearing in the Company’s Condensed Consolidated Statements of Comprehensive Income:

|  | Three Months Ended December 31, 2018 | 2017 | Nine Months Ended December 31, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of sales | 67.7 | 63.5 | 65.9 | 64.7 |
| Gross profit | 32.3 | 36.5 | 34.1 | 35.3 |
| Operating expenses: |  |  |  |  |
| General and administrative | 9.6 | 9.7 | 8.7 | 8.8 |
| Advertising | 6.0 | 6.8 | 7.1 | 7.2 |
| Depreciation | 0.9 | 0.9 | 0.8 | 0.8 |
| Total operating expenses | 16.5 | 17.4 | 16.6 | 16.8 |
| Income from operations | 15.8 | 19.1 | 17.5 | 18.5 |
| Total other income | 1.2 | 0.8 | 1.0 | 0.5 |
| Income before provision for income taxes | 17.0 | 19.9 | 18.5 | 19.0 |
| Provision for income taxes | 4.0 | 4.8 | 4.3 | 5.9 |
| Net income | 13.0% | 15.1% | 14.2% | 13.1% |

10

**Three Months Ended December 31, 2018 Compared With Three Months Ended December 31, 2017, and Nine Months Ended December 31, 2018 Compared With Nine Months Ended December 31, 2017**

### Sales

Sales were $60.1 million for the quarters ended December 31, 2018 and 2017. For the nine months ended December 31, 2018, sales increased by approximately $12.4 million, or 6.0%, to approximately $218.9 million compared to $206.5 million for the nine months ended December 31, 2017. The increase in sales for the nine months ended December 31, 2018 was primarily due to increased reorder sales. The Company acquired approximately 81,000 new customers for the quarter ended December 31, 2018, compared to approximately 106,000 new customers for the same period the prior year. For the nine months ended December 31, 2018 the Company acquired approximately 366,000 new customers, compared to 408,000 new customers for the nine months ended December 31, 2017. The following chart illustrates sales by various sales classifications:

*Three Months Ended December 31,*

|  |  |  |  |  |
| --- | ---: | ---: | ---: | ---: |
| **Sales (In thousands)** | **2018%** | **2017%** | **$ Variance** | **% Variance** |
| Reorder Sales | $53,289 88.7% | $50,949 84.8% | $2,340 | 4.6% |
| New Order Sales | 6,779 11.3% | 9,161 15.2% | (2,382) | -26.0% |
| Total Net Sales | $60,068 100.0% | $60,110 100.0% | $(42) | -0.1% |
| Internet Sales | $50,701 84.4% | $50,358 83.8% | $343 | 0.7% |
| Contact Center Sales | 9,367 15.6% | 9,752 16.2% | (385) | -3.9% |
| Total Net Sales | $60,068 100.0% | $60,110 100.0% | $(42) | -0.1% |

*Nine Months Ended December 31,*

|  |  |  |  |  |
| --- | ---: | ---: | ---: | ---: |
| **Sales (In thousands)** | **2018%** | **2017%** | **$ Variance** | **% Variance** |
| Reorder Sales | $185,866 84.9% | $170,487 82.6% | $15,379 | 9.0% |
| New Order Sales | 32,988 15.1% | 35,991 17.4% | (3,003) | -8.3% |
| Total Net Sales | $218,854 100.0% | $206,478 100.0% | $12,376 | 6.0% |
| Internet Sales | $185,320 84.7% | $173,175 83.9% | $12,145 | 7.0% |
| Contact Center Sales | 33,534 15.3% | 33,303 16.1% | 231 | 0.7% |
| Total Net Sales | $218,854 100.0% | $206,478 100.0% | $12,376 | 6.0% |

Going forward sales may be adversely affected due to increased competition and consumers giving more consideration to price. No guarantees can be made that sales will grow in the future. The majority of our product sales are affected by the seasons, due to the seasonality of mainly heartworm, and flea and tick medications. For the quarters ended June 30, September 30, December 31, and March 31 of Fiscal 2018, the Company’s sales were approximately 29%, 24%, 22%, and 25%, respectively.

### Cost of sales

Cost of sales increased by approximately $2.5 million, or 6.6%, to approximately $40.7 million for the quarter ended December 31, 2018, from approximately $38.2 million for the quarter ended December 31, 2017. For the nine months ended December 31, 2018, cost of sales increased by approximately $10.7 million, or 8.0%, to approximately $144.3 million compared to $133.6 million for the same period in the prior year. Cost of sales as a percent of sales was 67.7% and 63.5% for the quarters ended December 31, 2018 and 2017, respectively, and for the nine months ended December 31, 2018 and 2017 the cost of sales was 65.9% and 64.7%, respectively. The cost of sales increases and percentage increases can be attributed to increases in discounts given to customers to stimulate sales in response to increased online competition and an increase in product costs during the quarter and nine months ended December 31, 2018.

### Gross profit

Gross profit decreased by approximately $2.6 million, or 11.7%, to approximately $19.4 million for the quarter ended December 31, 2018, from approximately $21.9 million for the quarter ended December 31, 2017. For the nine months ended December 31, 2018 gross profit increased by approximately $1.7 million, or 2.3%, to approximately $74.6 million, compared to $72.9 million for the same period in the prior year. The decrease in gross profit for the quarter ended December 31, 2018 is related to increased discounts given to customers to stimulate sales. The increases in gross profit for the nine months ended December 31, 2018 is directly related to increased sales offset by increased discounts given to customers to stimulate sales. Gross profit as a percentage of sales was 32.3% and 36.5% for the three months ended December 31, 2018 and 2017, respectively, and for the nine months ended December 31, 2018 and 2017, gross profit was 34.1% and 35.3%, respectively. The gross profit percentage decreases for the quarter and nine months ended December 31, 2018 are mainly attributed to increased discounts given to customers to stimulate sales in response to increased online competition for the quarter and nine months.

### General and administrative expenses

General and administrative expenses for both quarters ended December 31, 2018 and 2017 was $5.8 million. General and administrative expenses as a percentage of sales was 9.6% and 9.7% for the quarters ended December 31, 2018 and 2017, respectively. The percentage decrease for the quarter ended December 31, 2018 can be attributed to a slight reduction in general and administrative expenses. For the nine months ended December 31, 2018, general and administrative expenses increased by approximately $705,000, or 3.9%, to approximately $18.9 million from approximately $18.2 million for the nine months ended December 31, 2017. The increase in general and administrative expenses for the nine months ended December 31, 2018 was primarily due to the following: a $286,000 increase in bank service fees; a $238,000 increase in property expenses; a $151,000 increase in payroll expenses, and a net increase of $30,000 in other expenses which included professional fees, telephone, bad debt, and office expenses.

### Advertising expenses

Advertising expenses decreased by approximately $507,000, or 12.3%, to approximately $3.6 million for the quarter ended December 31, 2018, from approximately $4.1 million for the quarter ended December 31, 2017. For the nine months ended December 31, 2018, advertising expenses increased by approximately $682,000, or 4.6%, to approximately $15.6 million compared to advertising expenses of approximately $14.9 million for the nine months ended December 31, 2017. The decrease in advertising expenses for the quarter ended December 31, 2018 can be attributed to a lower-than-expected consumer response, which may be attributed to increased online competition. The advertising expenditures for the three and nine months ended December 31, 2018 were intended to stimulate sales and acquire new customers. The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, increased to $45 for the quarter ended December 31, 2018 compared to $39 for the quarter ended December 31, 2017. For the nine months ended December 31, 2018 and 2017 the advertising costs of acquiring a new customer were $43 and $37, respectively. The increases to customer acquisition costs for the quarter and nine months ended December 31, 2018 can be attributed to increased costs and a lower-than-expected consumer response, which may be attributed to increased online competition. Advertising cost of acquiring a new customer can be impacted by the advertising environment, the effectiveness of our advertising creative, advertising spending, and price competition. Historically, the advertising environment fluctuates due to supply and demand. A more favorable advertising environment may positively impact future sales, whereas a less favorable advertising environment may negatively impact future sales.

As a percentage of sales, advertising expense was 6.0% and 6.8% for the quarters ended December 31, 2018 and 2017, respectively, and for the nine months ended December 31, 2018 and 2017 advertising expense was 7.1% and 7.2%, respectively. The decrease in advertising expense as a percentage of total sales for the quarter ended December 31, 2018 can be attributed to decreased advertising spending in the quarter. The Company currently anticipates advertising as a percentage of sales to be between approximately 7.0% and 8.0% for fiscal 2019. However, the advertising percentage will fluctuate quarter to quarter due to seasonality and advertising availability.

### Depreciation

Depreciation expense for the quarter ended December 31, 2018 increased by $24,000 to $556,000 compared to $532,000 for the quarter ended December 31, 2017. For the nine months ended December 31, 2018 depreciation expense increased by approximately $74,000 to $1.7 million compared to $1.6 million for the same period in the prior year. The increases to depreciation expense for the quarter and nine months ended December 31, 2018 can be attributed to an increase in new property and equipment additions.

### Other income

Other income increased by approximately $307,000 to approximately $763,000 for the quarter ended December 31, 2018 from approximately $456,000 for the quarter ended December 31, 2017. For the nine months ended December 31, 2018 other income increased by approximately $970,000 to approximately $2.1 million compared to approximately $1.2 million for the same period in the prior year. The increases to other income for the quarter and nine months ended December 31, 2018 are primarily attributed to increased interest income due to increased interest rates. Interest income may decrease in the future as the Company utilizes its cash balances on its share repurchase plan, with approximately $10.2 million remaining as of December 31, 2018, on any quarterly dividend payment, or on its operating activities.

### Provision for income taxes

For the quarters ended December 31, 2018 and 2017, the Company recorded an income tax provision of approximately $2.4 million and $2.9 million, respectively, and for the nine months ended December 31, 2018 and 2017, the Company recorded an income tax provision of approximately $9.4 million and $12.2 million, respectively. The effective tax rate for the quarter ended December 31, 2018 was approximately 23.5%, compared to 24.0% for the quarter ended December 31, 2017, and the effective tax rate for the nine months ended December 31, 2018 was approximately 23.2%, compared to 31.1% for the nine months ended December 31, 2017. The decrease to the income tax provision for the three months ended December 31, 2018 was due to a decrease in taxable income, and the decrease to the effective tax rate for the nine months ended December 31, 2018, was related to a decrease in the federal tax rate from 35.0% to 21.0% pursuant to the Tax Cuts and Jobs Act of 2017.

### Liquidity and Capital Resources

The Company’s working capital at December 31, 2018 and March 31, 2018 was $105.4 million and $87.1 million, respectively. The $18.3 million increase in working capital was primarily attributable to cash flow generated from operations, offset by dividends paid in the period. Net cash provided by operating activities was $32.0 million and $35.1 million for the nine months ended December 31, 2018 and 2017, respectively. This change can be mainly attributed to an increase in the Company’s net income and accounts payable balance, offset by an increase in the Company’s inventory balance and decrease in the income taxes payable balance, compared to the same period in the prior year. Net cash used in investing activities decreased to $507,000 for the nine months ended December 31, 2018, compared to net cash used in investing activities of $564,000 for the nine months ended December 31, 2017. Net cash used in financing activities was $16.3 million for the nine months ended December 31, 2018, compared to $12.3 million for the same period in the prior year, which represented an increase in dividends paid in the period ended December 31, 2018.

At December 31, 2018, the Company had approximately $10.2 million remaining under the Company’s share repurchase plan. Subsequent to December 31, 2018, on January 25, 2019 our Board of Directors authorized an additional $30.0 million under the Company’s share repurchase plan for a total of $40.2 million authorized for future share repurchases. Subsequent to December 31, 2018, on January 22, 2019 our Board of Directors declared a quarterly dividend of $0.27 per share. The Board established a February 4, 2019 record date and a February 15, 2019 payment date. Depending on future market conditions the Company may utilize its cash and cash equivalents on the remaining balance of its current share repurchase plan, on dividends, or on its operating activities. At December 31, 2018, the Company had no material outstanding lease commitments. We are not currently bound by any long or short term agreements for the purchase or lease of capital expenditures. Any material amounts expended for capital expenditures would be the result of an increase in the capacity needed to adequately provide for any increase in our business. To date we have paid for any needed additions to our capital equipment infrastructure from working capital funds and anticipate this being the case in the future. Presently, we have approximately $250,000 forecasted for capital expenditures for the remainder of fiscal 2019, which will be funded through cash from operations. The Company’s primary source of working capital is cash from operations. The Company presently has no need for alternative sources of working capital, and has no commitments or plans to obtain additional capital.

### Off-Balance Sheet Arrangements

The Company had no off-balance sheet arrangements at December 31, 2018.

### Cautionary Statement Regarding Forward-Looking Information

Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these forward-looking statements by the words "believes," "intends," "expects," "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," "predicts," "estimates," "anticipates," or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual future results may differ significantly from the results discussed in the forward-looking statements. A reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements, which apply only as of the date of this quarterly report. When used in this quarterly report on Form 10-Q, "PetMed Express," "1-800-PetMeds," "PetMeds," "PetMed," "PetMeds.com," “1800PetMeds.com,” "PetMed.com," "PetMed Express.com," "the Company," "we," "our," and "us" refers to PetMed Express, Inc. and our subsidiaries.

## Market risk

As filed, 1,537 characters.

Market risk generally represents the risk that losses may occur in the value of financial instruments as a result of movements in interest rates, foreign currency exchange rates, and commodity prices. Our financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The book values of cash equivalents, accounts receivable, and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. Interest rates affect our return on excess cash and cash equivalents. At December 31, 2018, we had $93.2 million in cash and cash equivalents, and a majority of our cash and cash equivalents generate interest income based on prevailing interest rates. A significant change in interest rates would impact the amount of interest income generated from our excess cash and cash equivalents. It would also impact the market value of our money market funds. Our cash equivalents are subject to market risk, primarily interest rate and credit risk. Our cash equivalents are managed by a limited number of outside professional managers within investment guidelines set by our Board of Directors. Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting our investments to high-quality debt instruments with both short and long term maturities. We do not hold any derivative financial instruments that could expose us to significant market risk. At December 31, 2018, we had no debt obligations.

## Controls and procedures

As filed, 1,365 characters.

The Company’s management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 promulgated under the Securities Exchange Act of 1934, as amended) as of the quarter ended December 31, 2018, the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective such that the information relating to our Company, including our consolidated subsidiaries, required to be disclosed by the Company in reports that it files or submits under the Exchange Act: (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 386 characters.

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition, results of operations, and trading price of our common stock. Please refer to our Annual Report on Form 10-K for Fiscal Year 2018 for additional information concerning these and other uncertainties that could negatively impact the Company.

Filed Jan 29, 2019.
Source: SEC EDGAR, the filing index for accession 0001437749-19-001477. Last ingested by Listed: Nov 13, 2026, 14:26 ET. No prices; not investment advice.
